Search results for " cell"
Article
Recombinant Adeno-Associated Virus Type 5 Production Process
A scalable recombinant adeno-associated virus (rAAV) type 5 production process was developed using transfected HEK293 suspension cells.
READ THE FULL ARTICLE >>
Webcast
Controlling Cell-Culture Process Variability
That is why we created a transparent, multi-source supplier network for cell-culture materials.
Webcast
Recovery of Biological Products XIX
proteins, peptides, cell and gene therapies including viral vectors and nucleic acid-based products ), a range of expression systems, universal and personalized therapies, and different facility desig…
Article
Trends in Outsourcing of Bioprocess Development
Growing numbers of conventional recombinant proteins and monoclonal antibodies, as well as next-generation molecules such as multispecifics, antibody-drug conjugates, and cell and gene therapies, are …
Article
Register now: Viral Vector Production for Gene Therapy
In partnership with NIBRT, our eLearning course, “Viral Vector Production for Gene Therapy”, is available on the award winning NIBRT Online Academy.
READ MORE >>
Article
Navigating Molecular Diversity
Are you working with biomolecules beyond mAbs?
Read more here >>
Article
Top Challenges to Overcome When Developing AAV Processes: Part 1 of 2
…transfection
4:27 – Three main challenges for downstream AAV process development, including cell lysis and the polishing step for full capsid enrichment
7:28 – Challenges associated wit…
Article
Setting Up Bioprocessing Systems for Digital Transformation
As John Liddell, chief technologist, Biologics, at CPI indicates, mAb processes can generate significant amounts of data because, in upstream processing, cell culture processes typically run for 14 da…
Article
Innovative Chromatography Resins Can Improve Purity and Quality
He concluded that conventional multi-step DSP development bears the increased risk of commercial viability, where yield, impurity levels (such as host cell proteins or product-related impurities) or o…
Article
Diamyd Medical Selects Cytiva’s FlexFactory Platform to Make Precision Medicine Type-1 Diabetes Vaccine
The first of its kind, the type-1 diabetes vaccine works to reprogram immune cells to prevent the destruction of pancreatic insulin-producing B-cells.
.